These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 403994)

  • 21. Differential ability of colonial types of Neisseria gonorrhoeae to produce infection cutaneous perforated plastic chambers in guinea-pigs and rabbits.
    Veale DR; Smith H; Witt KA; Marshall RB
    J Med Microbiol; 1975 May; 8(2):325-35. PubMed ID: 806688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complexity of immunogenicity of Neisseria gonorrhoeae in the guinea pig subcutaneous chamber model.
    Parsons NJ; Penn CW; Veale DR; Smith H
    J Gen Microbiol; 1980 Jun; 118(2):523-7. PubMed ID: 6777456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine host response to Neisseria gonorrhoeae upper genital tract infection reveals a common transcriptional signature, plus distinct inflammatory responses that vary between reproductive cycle phases.
    Francis IP; Islam EA; Gower AC; Shaik-Dasthagirisaheb YB; Gray-Owen SD; Wetzler LM
    BMC Genomics; 2018 Aug; 19(1):627. PubMed ID: 30134832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological and serological diversity of Neisseria gonorrhoeae: gonococcal serotypes and their relationship with immunotypes.
    Wong KH; Arko RJ; Logan LC; Bullard JC
    Infect Immun; 1976 Dec; 14(6):1297-301. PubMed ID: 826483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of outer membrane proteins in the survival of Neisseria gonorrhoeae P9 within guinea-pig subcutaneous chambers.
    McBride HM; Lambden PR; Heckels JE; Watt PJ
    J Gen Microbiol; 1981 Sep; 126(1):63-7. PubMed ID: 6801194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolutionary watershed of susceptibility to gonococcal infection.
    McGee ZA; Gregg CR; Johnson AP; Kalter SS; Taylor-Robinson D
    Microb Pathog; 1990 Aug; 9(2):131-9. PubMed ID: 2126057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and secretory antibody responses to Neisseria gonorrhoeae in patients with gonococcal infections.
    Tapchaisri P; Sirisinha S
    Br J Vener Dis; 1976 Dec; 52(6):374-80. PubMed ID: 827325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current research activities on gonorrhea at the Center for Disease Control.
    Kellogg DS
    Health Serv Rep; 1973 Jan; 88(1):13-22. PubMed ID: 4631384
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.
    Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
    J Clin Invest; 1993 Jan; 91(1):339-43. PubMed ID: 8423230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial hemagglutination by Neisseria gonorrhoeae.
    Koransky JR; Scales RW; Kraus SJ
    Infect Immun; 1975 Sep; 12(3):495-8. PubMed ID: 809353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonorrhoea in the chimpanzee. Infection with laboratory-passed gonococci and by natural transmission.
    Brown WJ; Lucas CT; Kuhn US
    Br J Vener Dis; 1972 Jun; 48(3):177-8. PubMed ID: 4627047
    [No Abstract]   [Full Text] [Related]  

  • 32. A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
    Shaughnessy J; Gulati S; Agarwal S; Unemo M; Ohnishi M; Su XH; Monks BG; Visintin A; Madico G; Lewis LA; Golenbock DT; Reed GW; Rice PA; Ram S
    J Immunol; 2016 Feb; 196(4):1732-40. PubMed ID: 26773149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell mediated immunity in experimental Neisseria gonorrhoeae infection.
    Kanungo R; Agarwal SC
    Indian J Med Res; 1982 Feb; 75():185-91. PubMed ID: 6806180
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic heterogeneity associated with pilus aggregation and autoagglutinability in Neisseria gonorrhoeae.
    Penn CW; Parsons NJ; Veale DR; Smith H
    J Gen Microbiol; 1980 Nov; 121(1):195-202. PubMed ID: 6166729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neisseria gonorrhoeae: vaginal clearance and its correlation with resistance to infection in subcutaneous chambers in orally immunized estradiol-primed mice.
    Arko RJ; Smith S; Chen CY
    Vaccine; 1997; 15(12-13):1344-8. PubMed ID: 9302742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human experimentation with Neisseria gonorrhoeae: progress and goals.
    Cohen MS; Cannon JG
    J Infect Dis; 1999 Mar; 179 Suppl 2():S375-9. PubMed ID: 10081510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae.
    So NS; Ostrowski MA; Gray-Owen SD
    J Immunol; 2012 Apr; 188(8):4008-22. PubMed ID: 22427638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunological mechanisms of Neisseria gonorrhoeae infection: An update].
    Li XC; Su XH
    Zhonghua Nan Ke Xue; 2018 May; 24(5):452-456. PubMed ID: 30171763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physicochemical and biological properties of the gonococcal allergen].
    Runova VF; Bednova VN; Kondu EI; Agilina MG; Danilova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):85-8. PubMed ID: 3925665
    [No Abstract]   [Full Text] [Related]  

  • 40. Neisseria gonorrhoeae catalase is not required for experimental genital tract infection despite the induction of a localized neutrophil response.
    Soler-García AA; Jerse AE
    Infect Immun; 2007 May; 75(5):2225-33. PubMed ID: 17296753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.